Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Xijun Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou,…. Hauptthemen laut MEDLINE: Ginsenosides, Mesenchymal Stem Cells, Glucose Transporter Type 1, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: the Science Foundation of Zhejiang Province, the National Natural Science Foundation of China, the Basic Scientific Research Project of Wenzhou Science and Technology Bureau.
Themen: Schlaganfall
Abstract (Originalsprache)
The transplantation of bone marrow mesenchymal stem cells (MSCs) in stroke is hindered by the restricted rates of survival and differentiation. Ginsenoside compound K (CK), is reported to have a neuroprotective effect and regulate energy metabolism. We applied CK to investigate if CK could promote the survival of MSCs and differentiation into brain microvascular endothelial‐like cells (BMECs), thereby alleviating stroke symptoms. Therefore, transwell and middle cerebral artery occlusion (MCAO) models were used to mimic oxygen and glucose deprivation (OGD) in vitro and in vivo, respectively. Our results demonstrated that CK had a good affinity for GLUT1, which increased the expression of GLUT1 and the production of ATP, facilitated the proliferation and migration of MSCs, and activated the HIF‐1α/VEGF signaling pathway to promote MSC differentiation. Moreover, CK cooperated with MSCs to protect BMECs, promote angiogenesis and vascular density, enhance neuronal and astrocytic proliferation, thereby reducing infarct volume and consequently improving neurobehavioral outcomes. These results suggest that the synergistic effects of CK and MSCs could potentially be a promising strategy for stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Zhejiang-US Joint Laboratory for Aging and Neurological Disease Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Xijun Chen
Förderung
- the Science Foundation of Zhejiang Province
- the National Natural Science Foundation of China
- the Basic Scientific Research Project of Wenzhou Science and Technology Bureau
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Qian, W., Zhang, Y., Zhao, P., Lin, X., Yang, S., Zhuge, Q., & Ni, H. (2024). Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8235
Vancouver
Chen X, Qian W, Zhang Y, Zhao P, Lin X, Yang S, et al. Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway. Phytotherapy Research. 2024. doi:10.1002/ptr.8235
BibTeX
@article{Chen2024,
author = {Chen, Xijun and Qian, Wenqi and Zhang, Ying and Zhao, Peiqi and Lin, Xiangxiang and Yang, Su and Zhuge, Qichuan and Ni, Haoqi},
title = {Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8235}
}
EUVIMED